The White House Opens a New Window. is proposing several policy shifts that would further solidify the role of pharmacy benefit managers in setting drug costs Opens a New Window. , stunning some in the health care industry who view it as a direct contradiction to President Trump's stated goal to eliminate the middleman price negotiators.
Trending:
Trump's drug price plan mixed bag for benefit managers